Company Management

mAbTree Biologics

Biotechnology Basel, Basel-stadt, Ch 8 employees

Employees: 8
Contacts: 1
Emails: 1

mabtree.com LinkedIn

mAbTree Biologics Overview

Headquarters: Basel, Basel-stadt, Ch
Website: mabtree.com
Industry: Biotechnology
Employees: 8
Founded: 2019

Keywords

Biosimilars monoclonal Antibodies (mAbs) Recombinant Protein Therapeutics Biologics oncology Hematology Biotechnology

About mAbTree Biologics

mABTree Biologics is a biotech company based in Basel, Switzerland, focused on developing affordable, innovative monoclonal antibody therapies for hematological cancers, such as myeloproliferative neoplasms (MPNs), and autoimmune diseases. Founded in 2019, mABTree aims to make cutting-edge immunotherapies more accessible to patients worldwide. Our lead product, MT-0002, is a fully human antibody targeting a unique tumor marker and has shown promising preclinical results, including tumor reduction and depletion of mutant hematopoietic stem cells in MPN models. We are preparing for clinical trials and seeking partnerships and investments to accelerate development and potential regulatory approval by 2025, with a strategy for orphan drug status to expedite availability in underserved areas of oncology and hematology.

mAbTree Biologics Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage

mAbTree Biologics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Antoine Raj	Chief Executive Officer at Mabtree	Zwingen, Basel-country, Switzerland	View
Raj Andhuvan	Director at Mcbitss and Mabtree	Zwingen, Basel-country, Switzerland	Email
Rajesh Jayachandran, Md Phd	Chief Scientific Officer, Nxi	Basel, Switzerland	View